Kaplan-Meier estimates for overall survival in the entire cohort and subgroup analyses. (A) Entire nonmalignant cohort. (B) Aplastic anemia (n = 1337). (C) Immune deficiency (n = 796). (D) Hemoglobinopathies (n = 656). (E) Histiocytic disorders (n = 432). (F) Bone marrow failure (n = 470). (G) Immunosuppressive conditioning (n = 759). (H) Reduced-intensity conditioning (n = 1820). (I) Myeloablative conditioning (n = 1439).